Literature DB >> 12657317

Toxicity of botulinum neurotoxins in central nervous system of mice.

Siro Luvisetto1, Ornella Rossetto, Cesare Montecucco, Flaminia Pavone.   

Abstract

Botulinum neurotoxins (BoNTs) act specifically on cholinergic nerve terminals, where they cause a sustained block of acetylcholine release, and therefore they are powerful tools to study the role of cholinergic neurons in neuronal processes. Peripheral effects of BoNTs are widely documented while central effects have not been studied. Here, we report for the first time on the central toxicity of BoNT serotypes A and B following their direct intracerebroventricular (icv) injection in CD1 mice. The LD50 values were found to be in the range 0.5-1.0 x 10(-6)mg/kg. We recorded the following signs preceding animal death: piloerection and weight decrease appear first, followed by temperature decrease, eyelid closure, loss of sensorimotor reflexes, dehydration, dyspnea. Mice died of heart or respiratory failure. The surviving mice recovered completely within 4-6 days and regained the initial healthy conditions. At sub-lethal doses, the same clinical signs appear in a lighter form and with a longer time course.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657317     DOI: 10.1016/s0041-0101(02)00370-7

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  14 in total

Review 1.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

Review 2.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.

Authors:  Zherong You; Hao Yang; Wenwen Xin; Lin Kang; Shan Gao; Junhong Wang; Tao Zhang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

5.  Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.

Authors:  Maciej Gasior; Rebecca Tang; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2013-06-14       Impact factor: 4.030

Review 6.  Entering neurons: botulinum toxins and synaptic vesicle recycling.

Authors:  Claudia Verderio; Ornella Rossetto; Carlotta Grumelli; Carolina Frassoni; Cesare Montecucco; Michela Matteoli
Journal:  EMBO Rep       Date:  2006-10       Impact factor: 8.807

7.  Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures.

Authors:  Anna Piotrowska; Katarzyna Popiolek-Barczyk; Flaminia Pavone; Joanna Mika
Journal:  Front Cell Infect Microbiol       Date:  2017-04-26       Impact factor: 5.293

8.  Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model.

Authors:  Alba Finocchiaro; Sara Marinelli; Federica De Angelis; Valentina Vacca; Siro Luvisetto; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2018-03-18       Impact factor: 4.546

9.  The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.

Authors:  Sara Marinelli; Valentina Vacca; Ruggero Ricordy; Carolina Uggenti; Ada Maria Tata; Siro Luvisetto; Flaminia Pavone
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Central nervous system toxicity after botulinum neurotoxin injection.

Authors:  Yashar Ilkhchoui; Ramsis F Ghaly; N Nick Knezevic; Kenneth D Candido
Journal:  Anesth Pain Med       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.